3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
3
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Advanced Solid Tumors
2
Solid Tumor
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Neutropenia
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Fever
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Interventions
fludarabine phosphate
31
Cyclophosphamide
27
Mycophenolic Acid
22
Whole-Body Irradiation
21
Tacrolimus
21
ruxolitinib
19
Peripheral Blood Stem Cell Transplantation
19
Busulfan
19
Antilymphocyte Serum
16
fludarabine
14
Melphalan
12
Methotrexate
11
Cyclosporine
10
thymoglobulin
9
Cord Blood Stem Cell Transplantation
7
Sirolimus
6
Radiotherapy
6
Etoposide
6
Azacitidine
6
Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporins
4
pomalidomide
3
parsaclisib
3
Surveys and Questionnaires
3
Rituximab
3
Prednisone
3
Filgrastim
3
Cytarabine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Primary Myelofibrosis
×
Itraconazole
×
Clear all
No trials found.